MAGINI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 588
EU - Europa 408
AS - Asia 127
AF - Africa 37
OC - Oceania 2
SA - Sud America 1
Totale 1.163
Nazione #
US - Stati Uniti d'America 588
GB - Regno Unito 114
SE - Svezia 62
CN - Cina 56
IT - Italia 48
DE - Germania 47
VN - Vietnam 31
IE - Irlanda 30
UA - Ucraina 26
IN - India 23
TG - Togo 21
RU - Federazione Russa 19
CH - Svizzera 15
FR - Francia 15
EE - Estonia 13
ZA - Sudafrica 9
BE - Belgio 7
BG - Bulgaria 4
IR - Iran 4
SG - Singapore 4
FI - Finlandia 3
JO - Giordania 3
NG - Nigeria 3
CI - Costa d'Avorio 2
JP - Giappone 2
NZ - Nuova Zelanda 2
AT - Austria 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
EG - Egitto 1
KR - Corea 1
LB - Libano 1
MK - Macedonia 1
MY - Malesia 1
PH - Filippine 1
SC - Seychelles 1
Totale 1.163
Città #
Southend 105
Chandler 97
Ashburn 43
Fairfield 43
Woodbridge 37
Dublin 30
Wilmington 29
Houston 27
Princeton 26
Cambridge 22
Seattle 22
Lomé 21
Jacksonville 16
Nanjing 16
Bern 15
Boardman 14
New York 14
Ann Arbor 11
Westminster 11
Padova 10
Bremen 7
Brussels 7
Dearborn 7
Saint Petersburg 7
Shenyang 7
Turin 7
Berlin 6
Jinan 6
Medford 6
Mountain View 5
Bologna 4
Changsha 4
Hebei 4
Jiaxing 4
Kuban 4
Redwood City 4
San Diego 4
Sofia 4
Tianjin 4
Abeokuta 3
Amman 3
Castelnuovo Don Bosco 3
Florence 3
Singapore 3
Abidjan 2
Des Moines 2
Helsinki 2
Monmouth Junction 2
Mülheim 2
Norwalk 2
Tokyo 2
Auckland 1
Beijing 1
Brno 1
Bühl 1
Cairo 1
Duino 1
Falls Church 1
Frankfurt Am Main 1
Fuzhou 1
Hefei 1
Kuala Lumpur 1
Kunming 1
Lanzhou 1
Lappeenranta 1
Leawood 1
London 1
Lugo 1
Mahé 1
Milan 1
Mumbai 1
Nanchang 1
Ningbo 1
Noicattaro 1
Olalla 1
Paris 1
Prilep 1
Pune 1
Quezon City 1
Quito 1
San Mateo 1
Taiyuan 1
Tallinn 1
Ulan-ude 1
Wuhan 1
Zanjan 1
Totale 774
Nome #
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. 150
Long-term beta-blockade shortens Qt interval prolongation in patients with liver cirrhosis 123
Telangiectasia as a presenting sign of Graves’ disease. 120
Daily profile of circulating c-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects. Relationship with renal function. 117
Differential diagnosis between focal nodular hyperplasia and hepatocellular adenoma: Potential role of double tracer PET with 11C-Acetate and 18F-FDG 103
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance. 101
Effects of the combined treatment with thalidomide and megestrol in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study. 100
Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis 96
How should the patients with HCC managed in the waiting list: the hepatologist perspective. 71
Impact of etiology of cirrhosis on HCC stage and on survival of patients under surveillance 71
The etiology of viral cirrhosis affects the survival od patients with hepatocellular carcinoma. A case-control study. 68
Beneficial prognostic effects of aspirin in patients receiving sorafenib for hepatocellular carcinoma: A tale of multiple confounders 66
Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic Liver Classification B) Receiving Systemic Therapy 7
Totale 1.193
Categoria #
all - tutte 3.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020272 52 7 2 14 28 29 37 30 36 12 9 16
2020/2021136 35 7 5 5 2 8 0 5 15 4 6 44
2021/2022271 10 8 10 11 20 11 7 11 18 20 91 54
2022/2023323 38 64 17 44 17 14 4 9 63 4 20 29
2023/202493 1 11 4 10 10 25 3 3 15 2 5 4
Totale 1.193